Eribulin plus pyrotinib In trastuzumab-resistant HER2-positive advanced breast cancer: A single-arm, multicenter phase II trial (EPIC trial). Association of pre-treatment HER2 amplicon mRNA signature, ...
UNOCHA says assessment will provide district-wise cropland and crop type damage to support planning for disaster response and recovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback